In particular, in molecularly targeted cancer therapy, targeted inhibition of the KRT80 gene, thereby attenuating the proliferation, invasion and metastatic ability of tumor cells and improving patient prognosis, is a promising potential therapeutic approach. Here, KRT80 is linked to neoplasm.